Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Grape skin extract: A new possibility in diabetes treatment

The diabetes rate in the United States nearly doubled in the past 10 years. Approximately 26 million Americans are now classified as diabetic, stressing an urgent need for safe and effective complementary strategies to enhance the existing conventional treatment for diabetes.

12 May 2014

Patients with Parkinson's disease show improvements after exenatide therapy

Follow-Up Study Published in the Journal of Parkinson's Disease Supports an Earlier "Proof of Concept" Trial. A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy.

9 May 2014

Low-carbohydrate diet reduces inflammation in patients with type 2 diabetes

A low-carbohydrate diet, but not a low-fat diet, reduces inflammation in patients with type 2 diabetes, according to research at Linköping University in Sweden.

8 May 2014

Mouse mothers can protect pups from developing type 1 diabetes by eating gluten-free diet

New experiments on mice show, that mouse mothers can protect their pups from developing type 1 diabetes by eating a gluten-free diet. According to preliminary studies by reseachers at the University of Copenhagen, the findings may apply to humans.

8 May 2014

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Ligand Pharmaceuticals Incorporated today reported financial results for the three months ended March 31, 2014, and provided an operating forecast and program updates.

7 May 2014

Covidien opens new facility in Turkey to expand training and research capabilities

Further expanding its training and research capabilities in emerging markets, Covidien plc (NYSE: COV), has officially opened its Covidien Center of Innovation Turkey (CCI Turkey).

7 May 2014

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals, Inc. today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013.

6 May 2014

Factors that lead to diabetes contribute to low milk supply in some new mothers

New studies provide fresh evidence that the same factors that lead to diabetes contribute to low milk supply in some new mothers.

6 May 2014

Researchers aim to take confusion out of food choices for people with type 2 diabetes

Aiming to take the confusion out of food choices for people diagnosed with type 2 diabetes is the aim of new research at Griffith University.

5 May 2014

Women with elevated levels of liver enzyme prior to pregnancy twice as likely to develop gestational diabetes

Women with high levels of a common liver enzyme measured prior to pregnancy were twice as likely to subsequently develop gestational diabetes than those with the lowest levels, according to a Kaiser Permanente study published today in the journal Diabetes Care.

5 May 2014

Isis Pharmaceuticals reports final data from ISIS-APOCIIIRx Phase 2 study in patients with FCS

Isis Pharmaceuticals, Inc. announced the final data from its Phase 2 study of ISIS-APOCIIIRx as a monotherapy in patients with familial chylomicronemia syndrome, or FCS.

2 May 2014

Tens of thousands of premature deaths could be prevented each year

Heart disease, cancer, chronic lower respiratory diseases, stroke, and unintentional injuries cause nearly 900,000 premature deaths in the US each year. A recent study showed that 20–40% of deaths from each of these causes could be prevented.

2 May 2014

Second Genome, Pfizer partner to conduct microbiome research to gain new insights into obesity

Second Genome announced today that it has entered into an agreement with Pfizer Inc. to conduct extensive microbiome research in a large observational study aimed at gaining new insights into obesity and metabolic disease.

2 May 2014

Sheffield professor awarded prestigious Camillo Golgi Prize for outstanding contribution to medicine

A CONSULTANT who first described how diabetic nerve damage is caused by impaired circulation of the nerves has been awarded one of the most coveted international prizes in medicine in recognition of his outstanding contribution to the field.

30 Apr 2014

Higher calcium intake appears to mitigate impact of some of the risk genes for type 2 diabetes

Study shows calcium intake mitigates genetic risk for increased body fat in African-American children, a population with historically low calcium intake and high risk for diabetes.

29 Apr 2014

Report focuses on behavioral issues linked with patients' self-management of type 2 diabetes

Clinical Therapeutics features a special report in its April issue focusing primarily on the behavioral issues associated with patients' self-management of type 2 diabetes.

29 Apr 2014

Severe diabetes linked to brain atrophy

Type 2 diabetes may be associated with brain degeneration, according to a new multicenter study published online in the journal Radiology. The study also found that, contrary to common clinical belief, diabetes may not be directly associated with small vessel ischemic disease, where the brain does not receive enough oxygenated blood.

29 Apr 2014

Research to understand how low blood sugars cause irregular heartbeats in diabetes

Dangerous overnight blood sugar levels often go undetected and cause prolonged periods of heart rhythm disturbances in older patients with Type 2 diabetes and associated heart problems, new research reveals.

29 Apr 2014

Young onset age heightens Type 2 diabetes complication risks

Patients who develop Type 2 diabetes before the age of 40 years have higher complication risks at any given age than those who develop it later in life, research shows.

28 Apr 2014

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia and Alimera Sciences.

28 Apr 2014

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Grape skin extract: A new possibility in diabetes treatment

Patients with Parkinson's disease show improvements after exenatide therapy

Low-carbohydrate diet reduces inflammation in patients with type 2 diabetes

Mouse mothers can protect pups from developing type 1 diabetes by eating gluten-free diet

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Covidien opens new facility in Turkey to expand training and research capabilities

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Factors that lead to diabetes contribute to low milk supply in some new mothers

Researchers aim to take confusion out of food choices for people with type 2 diabetes

Women with elevated levels of liver enzyme prior to pregnancy twice as likely to develop gestational diabetes

Isis Pharmaceuticals reports final data from ISIS-APOCIIIRx Phase 2 study in patients with FCS

Tens of thousands of premature deaths could be prevented each year

Second Genome, Pfizer partner to conduct microbiome research to gain new insights into obesity

Sheffield professor awarded prestigious Camillo Golgi Prize for outstanding contribution to medicine

Higher calcium intake appears to mitigate impact of some of the risk genes for type 2 diabetes

Report focuses on behavioral issues linked with patients' self-management of type 2 diabetes

Severe diabetes linked to brain atrophy

Research to understand how low blood sugars cause irregular heartbeats in diabetes

Young onset age heightens Type 2 diabetes complication risks

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in